# 89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme

> **NCT02410577** · NA · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 2 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** 89Zr-J591
- **DEVICE:** PET/CT Scan
- **DEVICE:** MRI
- **OTHER:** Blood draw

## Key facts

- **NCT ID:** NCT02410577
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2019-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02410577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02410577, "89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02410577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*